cbdMD, Inc.

Symbol: YCBD




Market price today

  • 0.0523

    P/E Ratio

  • 0.0007

    PEG Ratio

  • 2.26M

    MRK Cap

  • 0.00%

    DIV Yield

cbdMD, Inc. (YCBD) Stock Price & Analysis

Shares Outstanding


Gross Profit Margin


Operating Profit Margin


Net Profit Margin


Return on Assets


Return on Equity


Return on Capital Employed


Company general description and statistics

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
CEO:Mr. T. Ronan Kennedy
Full-time employees:52
Address:8845 Red Oak Boulevard

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. It also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name. The company distributes its products through its e-commerce Website, third-party e-commerce sites, wholesalers, and various brick and mortar retailers in the United States. It has a research partnership with the University of Mississippi to identify novel cannabinoids. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was incorporated in 2015 and is headquartered in Charlotte, North Carolina.

General Outlook

When we look at how much money they make before expenses, they keep 0.626% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -0.829%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 1.788%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 2.777% return, is a testament to cbdMD, Inc.'s adeptness in optimizing resource deployment. cbdMD, Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 2.481%. Furthermore, the proficiency of cbdMD, Inc. in capital utilization is underscored by a remarkable -2.131% return on capital employed.

Liquidity Ratios

Analyzing YCBD liquidity ratios reveals its financial health of the firm. The current ratio of 123.35% gauges short-term asset coverage for liabilities. The quick ratio (43.66%) assesses immediate liquidity, while the cash ratio (25.20%) indicates cash reserves.

Current Ratio123.35%
Quick Ratio43.66%
Cash Ratio25.20%

Profitability Ratios

YCBD profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -85.21% underscores its earnings before tax deductions. The effective tax rate stands at -9773.99%, revealing its tax efficiency. The net income per EBT, -209.81%, and the EBT per EBIT, 102.77%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -82.91%, we grasp its operational profitability.

Pretax Profit Margin-85.21%
Effective Tax Rate-9773.99%
Net Income per EBT-209.81%
EBT per EBIT102.77%
EBIT per Revenue-82.91%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 1.23, it details the span from stock purchase to revenue.

Days of Sales Outstanding44
Days of Inventory Outstanding156
Operating Cycle173.07
Days of Payables Outstanding65
Cash Conversion Cycle108
Receivables Turnover21.27
Payables Turnover5.59
Inventory Turnover2.34
Fixed Asset Turnover6.09
Asset Turnover1.55

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -0.79, and free cash flow per share, -0.90, depict cash generation on a per-share basis. The cash per share value, 0.51, showcases liquidity position. A payout ratio of 0.06 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, -0.10, offers insight into cash flow relative to sales.

Operating Cash Flow per Share-0.79
Free Cash Flow per Share-0.90
Cash per Share0.51
Payout Ratio0.06
Operating Cash Flow Sales Ratio-0.10
Free Cash Flow to Operating Cash Flow Ratio1.13
Cash Flow Coverage Ratio-0.70
Short Term Coverage Ratio-1.80
Capital Expenditure Coverage Ratio-7.71
Dividend Paid and Capex Coverage Ratio-0.79
Dividend Payout Ratio1.76

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 22.32%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.48, we discern the balance between debt and equity financing. The long-term debt to capitalization, 22.70%, and total debt to capitalization, 32.37%, ratios shed light on its capital structure. An interest coverage of 677.31 indicates its ability to manage interest expenses.

Debt Ratio22.32%
Debt Equity Ratio0.48
Long Term Debt to Capitalization22.70%
Total Debt to Capitalization32.37%
Interest Coverage677.31
Cash Flow to Debt Ratio-0.70
Company Equity Multiplier2.15

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 11.94, provides a glimpse into top-line earnings distributed across each share. Net income per share, -11.34, reflects the portion of profit attributed to each share. The book value per share, 4.47, represents the net asset value distributed per share, while the tangible book value per share, 2.87, excludes intangible assets.

Revenue Per Share11.94
Net Income Per Share-11.34
Book Value Per Share4.47
Tangible Book Value Per Share2.87
Shareholders Equity Per Share4.47
Interest Debt Per Share1.82
Capex Per Share-0.15

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -100.00%, indicates top-line expansion, while the gross profit growth, -100.00%, reveals profitability trends. EBIT growth, -75337.55%, and operating income growth, -75337.55%, offer insights into operational profitability progression. The net income growth, -36263.58%, showcases bottom-line expansion, and the EPS growth, -974.19%, measures the growth in earnings per share.

Revenue Growth-100.00%
Gross Profit Growth-100.00%
EBIT Growth-75337.55%
Operating Income Growth-75337.55%
Net Income Growth-36263.58%
EPS Growth-974.19%
EPS Diluted Growth-974.19%
Weighted Average Shares Growth3284.62%
Weighted Average Shares Diluted Growth3284.62%
5-Year Revenue Growth per Share-100.00%
3-Year Revenue Growth per Share-100.00%
5-Year Net Income Growth per Share-24930.19%
3-Year Net Income Growth per Share-203.69%
5-Year Shareholders Equity Growth per Share174.27%
3-Year Shareholders Equity Growth per Share-94.47%
Receivables Growth-100.00%
Inventory Growth-100.00%
Asset Growth-100.00%
Book Value per Share Growth749.13%
Debt Growth26130.77%
R&D Expense Growth-100.00%
SGA Expenses Growth-100.00%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 3,967,996.6, captures the company's total value, considering both debt and equity. Income quality, 0.19, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.40, gauges operational efficiency, while the research and development to revenue, 0.72%, highlights investment in innovation. The ratio of intangibles to total assets, 19.88%, indicates the value of non-physical assets, and capex to operating cash flow, 6.92%, measures reinvestment capability.

Enterprise Value3,967,996.6
Income Quality0.19
Sales General and Administrative to Revenue0.40
Research and Development to Revenue0.72%
Intangibles to Total Assets19.88%
Capex to Operating Cash Flow6.92%
Capex to Revenue-1.23%
Capex to Depreciation-10.16%
Stock-Based Compensation to Revenue1.42%
Graham Number33.76
Return on Tangible Assets-176.77%
Graham Net Net-1.20
Working Capital3,399,700
Tangible Asset Value5,812,194
Net Current Asset Value906,042
Average Receivables1,332,648
Average Payables1,971,438.5
Average Inventory4,154,443
Days Sales Outstanding18
Days Payables Outstanding76
Days of Inventory On Hand161

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 0.31, and the price to book ratio, 0.31, reflect the market's valuation relative to the company's book value. The price to sales ratio, 0.10, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -0.85, and price to operating cash flows, -0.93, gauge market valuation against cash flow metrics.

Price Book Value Ratio0.31
Price to Book Ratio0.31
Price to Sales Ratio0.10
Price Cash Flow Ratio-0.93
Enterprise Value Multiple0.04
Price Fair Value0.31
Price to Operating Cash Flow Ratio-0.93
Price to Free Cash Flows Ratio-0.85
Price to Tangible Book Ratio0.23
Enterprise Value to Sales0.16
Enterprise Value Over EBITDA0.54
EV to Operating Cash Flow-0.92
Earnings Yield-1101.22%
Free Cash Flow Yield-220.82%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of cbdMD, Inc. (YCBD) on the AMEX in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 0.052 in 2024.

What is the ticker symbol of cbdMD, Inc. stock?

The ticker symbol of cbdMD, Inc. stock is YCBD.

What is company IPO date?

IPO date of cbdMD, Inc. is 2017-11-17.

What is company current share price?

Current share price is 0.741 USD.

What is stock market cap today?

The market cap of stock today is 2256412.000.

What is PEG ratio in 2024?

The current 0.001 is 0.001 in 2024.

What is the number of employees in 2024?

In 2024 the company has 52.